Association of Hypertension, Diabetes, and Cardiovascular Disease with COVID-19 in Africa: Scoping Review Protocol
暂无分享,去创建一个
[1] Jun Li,et al. Association between smoking and COVID-19 severity: A multicentre retrospective observational study , 2022, Medicine.
[2] Y. Chawla,et al. Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression , 2022, Frontiers in Endocrinology.
[3] T. Boerma,et al. Health service utilisation during the COVID-19 pandemic in sub-Saharan Africa in 2020: a multicountry empirical assessment with a focus on maternal, newborn and child health services , 2022, BMJ Global Health.
[4] G. Putoto,et al. The impact of the COVID-19 pandemic on health service use in sub-Saharan Africa. , 2022, Public health action.
[5] L. Tomasoni,et al. The impact of COVID-19 on communicable and non-communicable diseases in Africa: a narrative review. , 2022, Le infezioni in medicina.
[6] S. Reid,et al. Non-communicable disease care and management in two sites of the Cape Town Metro during the first wave of COVID-19: A rapid appraisal , 2022, African journal of primary health care & family medicine.
[7] T. Pollard,et al. “I wouldn't survive it, as simple as that”: Syndemic vulnerability among people living with chronic non-communicable disease during the COVID-19 pandemic , 2021, SSM - Qualitative Research in Health.
[8] Kidane Tadesse Gebremariam,et al. The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response , 2021, BMJ Global Health.
[9] I. Bassett,et al. Effect modification by age of the association between obstructive lung diseases, smoking, and COVID-19 severity , 2021, BMJ Open Respiratory Research.
[10] C. S. Wesseh,et al. Disruptions in maternal and child health service utilization during COVID-19: analysis from eight sub-Saharan African countries , 2021, Health policy and planning.
[11] N. White,et al. Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis , 2021, medRxiv.
[12] F. Voltarelli,et al. Genetic susceptibility of COVID-19: a systematic review of current evidence , 2021, European Journal of Medical Research.
[13] O. Owopetu,et al. COVID-19: implications for NCDs and the continuity of care in Sub-Saharan Africa , 2021, Global health promotion.
[14] S. Pastakia,et al. Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary , 2021, Health systems and reform.
[15] Ankur Khajuria,et al. The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis , 2020, Journal of medical virology.
[16] J. McGowan,et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.
[17] Ariel Deardorff,et al. Open Science Framework (OSF) , 2017, Journal of the Medical Library Association : JMLA.
[18] D. Parker,et al. Guidance for conducting systematic scoping reviews , 2015, International journal of evidence-based healthcare.
[19] M. Engelgau,et al. Convergence of non-communicable and infectious diseases in low- and middle-income countries. , 2013, International journal of epidemiology.
[20] Clinical Spectrum of SARS-CoV-2 Infection , 2022 .